Terug
Dagbereik
€ 40,50
€ 42,02
52-Weeksbereik
€ 30,08
€ 62,18
Volume
384.872
50D / 200D Gem.
€ 41,39
/
€ 47,11
Vorige Slotkoers
€ 42,11
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -6,1 | 0,3 |
| P/B | 8,5 | 2,9 |
| ROE % | -132,9 | 3,7 |
| Net Margin % | -89,9 | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 56,88
+39.0%
Low: € 50,00
High: € 68,00
Forward K/W
21,7
Forward WPA
€ 1,94
WPA Groei (sch.)
+0,0%
Omzet Sch.
740 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 3,79
€ 3,68 – € 3,93
|
1,4 B | 1 |
| FY2029 |
€ 3,38
€ 3,29 – € 3,50
|
1,2 B | 1 |
| FY2028 |
€ 3,01
€ 2,81 – € 3,21
|
1 B | 2 |
Belangrijkste Punten
Debt/Equity of 0,02 — conservative balance sheet
Generating 170,73M in free cash flow
Capital efficient — spends only 0,12% of revenue on capex
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)50,58%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-132,86%
ROIC-106,00%
Net Margin-89,86%
Op. Margin-92,94%
Veiligheid
Debt / Equity
0,02
Current Ratio1,47
Interest Coverage0,00
Waardering
P/E Ratio
-6,10
P/B Ratio8,51
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 50,58% | Revenue Growth (3Y) | 41,71% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 587,86M | Net Income (TTM) | -528,26M |
| ROE | -132,86% | ROA | -70,93% |
| Gross Margin | 79,65% | Operating Margin | -92,94% |
| Net Margin | -89,86% | Free Cash Flow (TTM) | 170,73M |
| ROIC | -106,00% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,02 | Current Ratio | 1,47 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -6,10 | P/B Ratio | 8,51 |
| P/S Ratio | 5,48 | PEG Ratio | 0,00 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 3,22B | Enterprise Value | 3,02B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | 587,86M | 390,40M | 292,73M |
| Net Income | -528,26M | -11,93M | -108,14M |
| EPS (Diluted) | -5,19 | -0,15 | -1,39 |
| Gross Profit | 468,22M | 300,59M | 194,18M |
| Operating Income | -546,37M | -24,43M | -130,51M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Total Assets | 744,76M | 673,26M | 622,53M |
| Total Liabilities | 366,23M | 256,56M | 195,25M |
| Shareholders' Equity | 378,54M | 416,70M | 427,28M |
| Total Debt | 8,04M | 11,07M | 15,73M |
| Cash & Equivalents | 208,00M | 300,79M | 234,95M |
| Current Assets | 533,90M | 583,45M | 529,88M |
| Current Liabilities | 362,41M | 249,30M | 184,16M |